|
Market Closed -
Bombay S.E.
13:02:23 12/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 530.15 INR | +0.10% |
|
-0.30% | +20.12% |
| Market Cap | 37.29B 385M 344M 320M 291M 550M 552M 3.85B 1.51B 19.01B 1.45B 1.42B 61B | P/E 2025 |
35.6x | P/E 2026 | 8.19x |
|---|---|---|---|---|---|
| Enterprise Value | 39.39B 407M 364M 338M 308M 581M 583M 4.07B 1.59B 20.08B 1.53B 1.5B 64.45B | EV / Sales 2025 |
2.49x | EV / Sales 2026 | 1.03x |
| Free-Float |
28.74% | Yield 2025 * |
-
| Yield 2026 | - |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| UNICHEMLAB | Delayed | |
NSE India S.E.
| UNICHEMLAB | Delayed |
| 1 day | +0.10% | ||
| 1 week | -0.30% | ||
| Current month | -2.97% | ||
| 1 month | +1.83% | ||
| 3 months | -11.21% | ||
| 6 months | +57.27% | ||
| Current year | +20.12% |
| 1 week | 520 |  | 568.75 |
| 1 month | 499.25 | | 604 |
| Current year | 280 | | 685.95 |
| 1 year | 280 | | 685.95 |
| 3 years | 280 | | 949.85 |
| 5 years | 197.5 | | 949.85 |
| 10 years | 75.1 | | 949.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 10/08/2023 | |
Sanjay Jain
DFI | Director of Finance/CFO | - | 08/08/2024 |
Dhananjay Sathe
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 22/08/1977 | |
Pranay Godha
BRD | Director/Board Member | 53 | 10/08/2023 |
| Director/Board Member | 57 | 10/08/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.10% | -0.30% | +11.12% | +25.75% | 385M | |
| +0.40% | +3.48% | +44.36% | +93.76% | 1,051B | |
| +0.34% | +3.95% | +37.73% | +68.19% | 630B | |
| +1.04% | +4.82% | +20.96% | +87.84% | 489B | |
| -0.01% | +4.10% | +69.50% | +40.23% | 359B | |
| +0.74% | +3.41% | +24.37% | +42.78% | 344B | |
| +0.57% | +3.00% | +14.81% | +34.73% | 272B | |
| -0.28% | +1.79% | -5.89% | +7.68% | 246B | |
| +0.23% | +3.17% | +42.19% | +45.86% | 224B | |
| -0.05% | +4.75% | +28.16% | +97.37% | 187B | |
| Average | +0.28% | +2.46% | +28.73% | +54.42% | 380.41B | |
| Weighted average by Cap. | +0.32% | +2.93% | +34.52% | +66.64% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 21.11B 218M 195M 181M 165M 311M 313M 2.18B 855M 10.76B 819M 801M 34.54B | 22.02B 228M 203M 189M 172M 325M 326M 2.27B 891M 11.23B 854M 836M 36.02B |
| Net income | 1.38B 14.21M 12.69M 11.81M 10.74M 20.27M 20.36M 142M 55.67M 701M 53.36M 52.19M 2.25B | 2.53B 26.13M 23.33M 21.7M 19.74M 37.28M 37.44M 261M 102M 1.29B 98.1M 95.96M 4.14B |
| Net Debt | 3.7B 38.25M 34.16M 31.78M 28.91M 54.58M 54.81M 382M 150M 1.89B 144M 140M 6.06B | 2.11B 21.77M 19.44M 18.08M 16.45M 31.06M 31.19M 218M 85.28M 1.07B 81.74M 79.96M 3.45B |
Employees
2,780
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/10/26 | ₹530.15 | +0.10% | 1,414 |
| 09/10/26 | ₹529.60 | +0.09% | 2,131 |
| 08/10/26 | ₹529.10 | -2.97% | 6,532 |
| 07/10/26 | ₹545.30 | -0.31% | 4,647 |
| 06/10/26 | ₹547.00 | +2.87% | 5,217 |
- Stock Market
- Stocks
- UNICHEMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
